170 related articles for article (PubMed ID: 31343410)
1. Evaluation of adherence to the Commission on Cancer lung cancer quality measures.
Odell DD; Feinglass J; Engelhardt K; Papastefan S; Meyerson SL; Bharat A; DeCamp MM; Bilimoria KY
J Thorac Cardiovasc Surg; 2019 Mar; 157(3):1219-1235. PubMed ID: 31343410
[TBL] [Abstract][Full Text] [Related]
2. Institutional factors associated with adherence to quality measures for stage I and II non-small cell lung cancer.
Khorfan R; Cooke DT; Meguid RA; Backhus L; Varghese TK; Farjah F; Bilimoria KY; Odell DD;
J Thorac Cardiovasc Surg; 2021 Sep; 162(3):649-660.e8. PubMed ID: 34144822
[TBL] [Abstract][Full Text] [Related]
3. Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity?
Bott MJ; Patel AP; Verma V; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1549-1558.e2. PubMed ID: 27207124
[TBL] [Abstract][Full Text] [Related]
4. Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.
Veeramachaneni NK; Feins RH; Stephenson BJ; Edwards LJ; Fernandez FG
Ann Thorac Surg; 2012 Sep; 94(3):922-6; discussion 926-8. PubMed ID: 22742842
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
Brandt WS; Yan W; Zhou J; Tan KS; Montecalvo J; Park BJ; Adusumilli PS; Huang J; Bott MJ; Rusch VW; Molena D; Travis WD; Kris MG; Chaft JE; Jones DR
J Thorac Cardiovasc Surg; 2019 Feb; 157(2):743-753.e3. PubMed ID: 30415902
[TBL] [Abstract][Full Text] [Related]
6. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
[TBL] [Abstract][Full Text] [Related]
7. Evolution in the Surgical Care of Patients With Non-Small Cell Lung Cancer in the Mid-South Quality of Surgical Resection Cohort.
Faris NR; Smeltzer MP; Lu F; Fehnel CL; Chakraborty N; Houston-Harris CL; Robbins ET; Signore RS; McHugh LM; Wolf BA; Wiggins L; Levy P; Sachdev V; Osarogiagbon RU
Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):91-101. PubMed ID: 28684006
[TBL] [Abstract][Full Text] [Related]
8. Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio.
Shinde A; Horne ZD; Li R; Glaser S; Massarelli E; Koczywas M; Erhunmwunsee L; Reckamp KL; Weksler B; Salgia R; Beriwal S; Amini A
Lung Cancer; 2019 Jul; 133():136-143. PubMed ID: 31200820
[TBL] [Abstract][Full Text] [Related]
9. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes.
Visser BC; Ma Y; Zak Y; Poultsides GA; Norton JA; Rhoads KF
HPB (Oxford); 2012 Aug; 14(8):539-47. PubMed ID: 22762402
[TBL] [Abstract][Full Text] [Related]
10. Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung Cancer.
Ye JC; Ding L; Atay SM; Nieva JJ; McFadden PM; Chang E; Kim AW
Semin Thorac Cardiovasc Surg; 2020; 32(1):153-159. PubMed ID: 31220530
[TBL] [Abstract][Full Text] [Related]
11. Development of Quality Indicators of Stroke Centers and Feasibility of Their Measurement Using a Nationwide Insurance Claims Database in Japan ― J-ASPECT Study ―.
Nishimura A; Nishimura K; Onozuka D; Matsuo R; Kada A; Kamitani S; Higashi T; Ogasawara K; Shimodozono M; Harada M; Hashimoto Y; Hirano T; Hoshino H; Itabashi R; Itoh Y; Iwama T; Kohriyama T; Matsumaru Y; Osato T; Sasaki M; Shiokawa Y; Shimizu H; Takekawa H; Nishi T; Uno M; Yagita Y; Ido K; Kurogi A; Kurogi R; Arimura K; Ren N; Hagihara A; Takizawa S; Arai H; Kitazono T; Miyamoto S; Minematsu K; Iihara K;
Circ J; 2019 Oct; 83(11):2292-2302. PubMed ID: 31554766
[TBL] [Abstract][Full Text] [Related]
12. Association Between Hospital Recognition for Resuscitation Guideline Adherence and Rates of Survival for In-Hospital Cardiac Arrest.
Khera R; Tang Y; Link MS; Krumholz HM; Girotra S; Chan PS
Circ Cardiovasc Qual Outcomes; 2019 Mar; 12(3):e005429. PubMed ID: 30871337
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Patients With pN2 "Potentially Resectable" Nonsmall Cell Lung Cancer Who Underwent Surgery After Induction Chemotherapy.
Spaggiari L; Casiraghi M; Guarize J; Brambilla D; Petrella F; Maisonneuve P; De Marinis F
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):593-602. PubMed ID: 28043483
[TBL] [Abstract][Full Text] [Related]
14. Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy.
Saisho S; Yasuda K; Maeda A; Yukawa T; Okita R; Hirami Y; Shimizu K; Nakata M
Interact Cardiovasc Thorac Surg; 2013 Feb; 16(2):166-72. PubMed ID: 23143203
[TBL] [Abstract][Full Text] [Related]
15. Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis.
Toyooka S; Kiura K; Shien K; Katsui K; Hotta K; Kanazawa S; Date H; Miyoshi S
Interact Cardiovasc Thorac Surg; 2012 Dec; 15(6):954-60. PubMed ID: 22976995
[TBL] [Abstract][Full Text] [Related]
16. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer.
Toubat O; Atay SM; Kim AW; Ding L; Farias AJ; Ebner PJ; McFadden PM; David EA
Ann Thorac Surg; 2020 May; 109(5):1512-1520. PubMed ID: 31982443
[TBL] [Abstract][Full Text] [Related]
17. Timeliness of lung cancer diagnosis and treatment: a single-center experience.
Rao SS; Saha S
Asian Cardiovasc Thorac Ann; 2019 Oct; 27(8):670-676. PubMed ID: 31569945
[No Abstract] [Full Text] [Related]
18. Factors Associated With Survival in Complete Pathologic Response Non-Small Cell Lung Cancer.
Martinez-Meehan D; Lutfi W; Dhupar R; Christie N; Baker N; Schuchert M; Luketich JD; Okusanya OT
Clin Lung Cancer; 2020 Jul; 21(4):349-356. PubMed ID: 32299769
[TBL] [Abstract][Full Text] [Related]
19. The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer.
Rogers LJ; Bleetman D; Messenger DE; Joshi NA; Wood L; Rasburn NJ; Batchelor TJP
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1843-1852. PubMed ID: 29352586
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of early-stage non-small cell lung carcinoma and the present and future roles of adjuvant therapy: a review for the radiation oncologist.
Medford-Davis L; Decamp M; Recht A; Flickinger J; Belani CP; Varlotto J
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1048-57. PubMed ID: 22632771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
